{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anticancer drugs", "chemotherapeutic agent", "drug design and development", "heterocyclic compounds", "isatin derivatives", "therapeutic targeting"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35337070", "DateRevised": {"Year": "2022", "Month": "03", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "02", "Day": "22"}], "Language": ["eng"], "ELocationID": ["272", "10.3390/ph15030272"], "Journal": {"ISSN": "1424-8247", "JournalIssue": {"Volume": "15", "Issue": "3", "PubDate": {"Year": "2022", "Month": "Feb", "Day": "22"}}, "Title": "Pharmaceuticals (Basel, Switzerland)", "ISOAbbreviation": "Pharmaceuticals (Basel)"}, "ArticleTitle": "Therapeutic Outcomes of Isatin and Its Derivatives against Multiple Diseases: Recent Developments in Drug Discovery.", "Abstract": {"AbstractText": ["Isatin (1<i>H</i> indole 2, 3-dione) is a heterocyclic, endogenous lead molecule recognized in humans and different plants. The isatin nucleus and its derivatives are owed the attention of researchers due to their diverse pharmacological activities such as anticancer, anti-TB, antifungal, antimicrobial, antioxidant, anti-inflammatory, anticonvulsant, anti-HIV, and so on. Many research chemists take advantage of the gentle structure of isatins, such as NH at position 1 and carbonyl functions at positions 2 and 3, for designing biologically active analogues via different approaches. Literature surveys based on reported preclinical, clinical, and patented details confirm the multitarget profile of isatin analogues and thus their importance in the field of medicinal chemistry as a potent chemotherapeutic agent. This review represents the recent development of isatin analogues possessing potential pharmacological action in the years 2016-2020. The structure-activity relationship is also discussed to provide a pharmacophoric pattern that may contribute in the future to the design and synthesis of potent and less toxic therapeutics."]}, "AuthorList": [{"Identifier": ["0000-0002-3111-6896"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Dr. Rajendra Gode College of Pharmacy, Malkapur 443101, Maharashtra, India."}], "LastName": "Cheke", "ForeName": "Rameshwar S", "Initials": "RS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, KIET School of Pharmacy, KIET Group of Institutions, Delhi-NCR, Ghaziabad 201206, Uttar Pradesh, India."}], "LastName": "Patil", "ForeName": "Vaishali M", "Initials": "VM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur 425405, Maharashtra, India."}], "LastName": "Firke", "ForeName": "Sandip D", "Initials": "SD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Dr. Rajendra Gode College of Pharmacy, Malkapur 443101, Maharashtra, India."}], "LastName": "Ambhore", "ForeName": "Jaya P", "Initials": "JP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur 425405, Maharashtra, India."}], "LastName": "Ansari", "ForeName": "Iqrar A", "Initials": "IA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur 425405, Maharashtra, India."}], "LastName": "Patel", "ForeName": "Harun M", "Initials": "HM"}, {"Identifier": ["0000-0002-9884-269X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Shri. R. D. Bhakt College of Pharmacy, Jalna 431213, Maharashtra, India."}], "LastName": "Shinde", "ForeName": "Sachin D", "Initials": "SD"}, {"Identifier": ["0000-0002-4454-3408"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Sciences and Therapeutics, Faculty of Medicine & Health Sciences, University Malaysia Sabah, Kota Kinabalu 44800, Sabah, Malaysia."}, {"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Medicine and Health Sciences, Abdurrab University, Pekanbaru 28291, Riau, Indonesia."}, {"Identifier": [], "Affiliation": "Centre for International Collaboration and Research, Reva University, Rukmini Knowledge Park, Kattigenahalli, Yelahanka, Bangalore 560064, Karnataka, India."}], "LastName": "Pasupuleti", "ForeName": "Visweswara Rao", "Initials": "VR"}, {"Identifier": ["0000-0002-3663-4940"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India."}], "LastName": "Hassan", "ForeName": "Md Imtaiyaz", "Initials": "MI"}, {"Identifier": ["0000-0002-7080-6822"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, College of Science, University of Hail, Hail P.O. Box 2440, Ha'il 2440, Saudi Arabia."}], "LastName": "Adnan", "ForeName": "Mohd", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Science of Sfax, Department of Chemistry, University of Sfax, B.P. 1171, Sfax 3000, Tunisia."}, {"Identifier": [], "Affiliation": "Faculty of Science and Arts in Baljurashi, Albaha University, P.O. Box 1988, Albaha 65527, Saudi Arabia."}], "LastName": "Kadri", "ForeName": "Adel", "Initials": "A"}, {"Identifier": ["0000-0002-2309-2601"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, College of Science, University of Hail, Hail P.O. Box 2440, Ha'il 2440, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Laboratory of Genetics, Biodiversity and Valorization of Bio-Resources (LR11ES41), University of Monastir, Higher Institute of Biotechnology of Monastir, Avenue Tahar Haddad, BP74, Monastir 5000, Tunisia."}], "LastName": "Snoussi", "ForeName": "Mejdi", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceuticals (Basel)", "NlmUniqueID": "101238453", "ISSNLinking": "1424-8247"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Akhtar J., Khan A.A., Ali Z., Haider R., Shahar Yar M. Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities. Eur. J. Med. Chem. 2017;125:143\u2013189. doi: 10.1016/j.ejmech.2016.09.023.", "ArticleIdList": ["10.1016/j.ejmech.2016.09.023", "27662031"]}, {"Citation": "Kerru N., Gummidi L., Maddila S., Gangu K.K., Jonnalagadda S.B. A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications. Molecules. 2020;25:1909. doi: 10.3390/molecules25081909.", "ArticleIdList": ["10.3390/molecules25081909", "PMC7221918", "32326131"]}, {"Citation": "Cheke R.S., Shinde S.D., Ambhore J.P., Chaudhari S.R., Bari S.B. Quinazoline: An update on current status against convulsions. J. Mol. Struct. 2022;1248:131384. doi: 10.1016/j.molstruc.2021.131384.", "ArticleIdList": ["10.1016/j.molstruc.2021.131384"]}, {"Citation": "Varun, Sonam, Kakkar R. Isatin and its derivatives: A survey of recent syntheses, reactions, and applications. Med. Chem. Commun. 2019;10:351\u2013368. doi: 10.1039/C8MD00585K.", "ArticleIdList": ["10.1039/C8MD00585K", "PMC6438150", "30996856"]}, {"Citation": "Borad M., Bhoi M., Prajapati N., Patel D., Francis T. Synthetic Communications: An International Journal for Rapid Communication of Synthetic Organic Chemistry Publication details, including instructions for authors and subscription information Review of Synthesis of Spiro Heterocyclic Compounds from Isatin. Synth. Commun. 2013;447:897\u2013922. doi: 10.1080/00397911.2013.843196.", "ArticleIdList": ["10.1080/00397911.2013.843196"]}, {"Citation": "Yoshikawa M., Murakami T., Kishi A., Sakurama T., Matsuda H., Nomura M., Matsuda H., Kubo M. Novel Indole S, O-Bisdesmoside, Calanthoside, The Precursor Glycoside of Tryptanthrin, Indirubin, and Isatin, with Increasing Skin Blood Flow Promoting Effects, from Two Calanthe Species (Orchidaceae) Chem. Pharm. Bull. 1998;46:886\u2013888. doi: 10.1248/cpb.46.886.", "ArticleIdList": ["10.1248/cpb.46.886", "9621425"]}, {"Citation": "Bergman J., Lindstr\u00f6m J.-O., Tilstam U. The structure and properties of some indolic constituents in Couroupita guianensis aubl. Tetrahedron. 1985;41:2879\u20132881. doi: 10.1016/S0040-4020(01)96609-8.", "ArticleIdList": ["10.1016/S0040-4020(01)96609-8"]}, {"Citation": "Khan F., Maalik A. Advances in Pharmacology of Isatin and its Derivatives: A Review. Trop. J. Pharm. Res. 2015;14:1937. doi: 10.4314/tjpr.v14i10.28.", "ArticleIdList": ["10.4314/tjpr.v14i10.28"]}, {"Citation": "Chiyanzu I., Hansell E., Gut J., Rosenthal P.J., McKerrow J.H., Chibale K. Synthesis and evaluation of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain. Bioorg. Med. Chem. Lett. 2003;13:3527\u20133530. doi: 10.1016/S0960-894X(03)00756-X.", "ArticleIdList": ["10.1016/S0960-894X(03)00756-X", "14505663"]}, {"Citation": "Ke S., Shi L., Yang Z. Discovery of novel isatin\u2013dehydroepiandrosterone conjugates as potential anticancer agents. Bioorg. Med. Chem. Lett. 2015;25:4628\u20134631. doi: 10.1016/j.bmcl.2015.08.041.", "ArticleIdList": ["10.1016/j.bmcl.2015.08.041", "26320625"]}, {"Citation": "Pawar V.S., Lokwani D.K., Bhandari S.V., Bothara K.G., Chitre T.S., Devale T.L., Modhave N.S., Parikh J.K. Design, docking study and ADME prediction of Isatin derivatives as anti-HIV agents. Med. Chem. Res. 2011;20:370\u2013380. doi: 10.1007/s00044-010-9329-y.", "ArticleIdList": ["10.1007/s00044-010-9329-y"]}, {"Citation": "Abbas S.Y., Farag A.A., Ammar Y.A., Atrees A.A., Mohamed A.F., El-Henawy A.A. Synthesis, characterization, and antiviral activity of novel fluorinated isatin derivatives. Mon. Fur Chem. 2013;144:1725\u20131733. doi: 10.1007/s00706-013-1034-3.", "ArticleIdList": ["10.1007/s00706-013-1034-3", "PMC7087807", "32214479"]}, {"Citation": "Liang C., Xia J., Lei D., Li X., Yao Q., Gao J. Synthesis, in vitro and in vivo antitumor activity of symmetrical bis-Schiff base derivatives of isatin. Eur. J. Med. Chem. 2014;74:742\u2013750. doi: 10.1016/j.ejmech.2013.04.040.", "ArticleIdList": ["10.1016/j.ejmech.2013.04.040", "24176732"]}, {"Citation": "Jarrahpour A., Sheikh J., El Mounsi I., Juneja H., Hadda T. Ben Computational evaluation and experimental in vitro antibacterial, antifungal and antiviral activity of bis-Schiff bases of isatin and its derivatives. Med. Chem. Res. 2013;22:1203\u20131211. doi: 10.1007/s00044-012-0127-6.", "ArticleIdList": ["10.1007/s00044-012-0127-6"]}, {"Citation": "Raj R., Biot C., Carr\u00e8re-Kremer S., Kremer L., Gu\u00e9rardel Y., Gut J., Rosenthal P.J., Forge D., Kumar V. 7-Chloroquinoline\u2013isatin Conjugates: Antimalarial, Antitubercular, and Cytotoxic Evaluation. Chem. Biol. Drug Des. 2014;83:622\u2013629. doi: 10.1111/cbdd.12273.", "ArticleIdList": ["10.1111/cbdd.12273", "24341638"]}, {"Citation": "Venkateshwarlu D., Kulandaivelu U., Sheshagiri S., Jupalli V. Evaluation of Antioxidant, Antimicrobial and Anticancer activity of Thiazole Tagged Isatin Hydrazones. J. Pharm. Chem. 2016;3:4. doi: 10.14805/jphchem.2016.art52.", "ArticleIdList": ["10.14805/jphchem.2016.art52"]}, {"Citation": "Rajanarendar E., Ramakrishna S., Govardhan Reddy K., Nagaraju D., Reddy Y.N. A facile synthesis, anti-inflammatory and analgesic activity of isoxazolyl-2,3-dihydrospiro[benzo[f]isoindole-1,3\u2032-indoline]-2\u2032,4,9-triones. Bioorg. Med. Chem. Lett. 2013;23:3954\u20133958. doi: 10.1016/j.bmcl.2013.04.053.", "ArticleIdList": ["10.1016/j.bmcl.2013.04.053", "23673015"]}, {"Citation": "El-Faham A., Hozzein W.N., Wadaan M.A.M., Khattab S.N., Ghabbour H.A., Fun H.-K., Siddiqui M.R. Microwave Synthesis, Characterization, and Antimicrobial Activity of Some Novel Isatin Derivatives. J. Chem. 2015;2015:716987. doi: 10.1155/2015/716987.", "ArticleIdList": ["10.1155/2015/716987"]}, {"Citation": "Mondal P., Jana S., Balaji A., Ramakrishna R., Kanthal L.K. Synthesis of Some New Isoxazoline Derivatives of Chalconised Indoline 2-one as a Potential Analgesic, Antibacterial and Anthelmimtic Agents. J. Young Pharm. 2012;4:38\u201341. doi: 10.4103/0975-1483.93574.", "ArticleIdList": ["10.4103/0975-1483.93574", "PMC3326781", "22523459"]}, {"Citation": "Firke S., Cheke R., Ugale V., Khadse S., Gagarani M., Surana S.B. Rationale design, synthesis, and pharmacological evaluation of isatin analogues as antiseizure agents. Lett. Drug Des. Discov. 2021;18:1. doi: 10.2174/1570180818666210804145014.", "ArticleIdList": ["10.2174/1570180818666210804145014"]}, {"Citation": "Guo H. Isatin derivatives and their anti-bacterial activities. Eur. J. Med. Chem. 2019;164:678\u2013688. doi: 10.1016/j.ejmech.2018.12.017.", "ArticleIdList": ["10.1016/j.ejmech.2018.12.017", "30654239"]}, {"Citation": "Xu Z., Zhang S., Gao C., Fan J., Zhao F., Lv Z.-S., Feng L.-S. Isatin hybrids and their anti-tuberculosis activity. Chin. Chem. Lett. 2017;28:159\u2013167. doi: 10.1016/j.cclet.2016.07.032.", "ArticleIdList": ["10.1016/j.cclet.2016.07.032"]}, {"Citation": "Ding Z., Zhou M., Zeng C. Recent advances in isatin hybrids as potential anticancer agents. Arch. Pharm. 2020;353:1900367. doi: 10.1002/ardp.201900367.", "ArticleIdList": ["10.1002/ardp.201900367", "31960987"]}, {"Citation": "Xu Z., Zhao S.-J., Lv Z.-S., Gao F., Wang Y., Zhang F., Bai L., Deng J.-L. Fluoroquinolone-isatin hybrids and their biological activities. Eur. J. Med. Chem. 2019;162:396\u2013406. doi: 10.1016/j.ejmech.2018.11.032.", "ArticleIdList": ["10.1016/j.ejmech.2018.11.032", "30453247"]}, {"Citation": "Cheke R.S., Firke S.D., Patil R.R., Bari S.B. Isatin: New hope against convulsion. Cent. Nerv. Syst. Agents Med. Chem. 2018;18:76\u2013101. doi: 10.2174/1871524917666171113124112.", "ArticleIdList": ["10.2174/1871524917666171113124112", "29141569"]}, {"Citation": "Ibrahim H.S., Abou-seri S.M., Ismail N.S.M., Elaasser M.M., Aly M.H., Abdel-Aziz H.A. Bis-isatin hydrazones with novel linkers: Synthesis and biological evaluation as cytotoxic agents. Eur. J. Med. Chem. 2016;108:415\u2013422. doi: 10.1016/j.ejmech.2015.11.047.", "ArticleIdList": ["10.1016/j.ejmech.2015.11.047", "26706352"]}, {"Citation": "Teng Y.-O., Zhao H.-Y., Wang J., Liu H., Gao M.-L., Zhou Y., Han K.-L., Fan Z.-C., Zhang Y.-M., Sun H., et al. Synthesis and anti-cancer activity evaluation of 5-(2-carboxyethenyl)-isatin derivatives. Eur. J. Med. Chem. 2016;112:145\u2013156. doi: 10.1016/j.ejmech.2015.12.050.", "ArticleIdList": ["10.1016/j.ejmech.2015.12.050", "26890120"]}, {"Citation": "Yu B., Wang S.-Q., Qi P.-P., Yang D.-X., Tang K., Liu H.-M. Design and synthesis of isatin/triazole conjugates that induce apoptosis and inhibit migration of MGC-803 cells. Eur. J. Med. Chem. 2016;124:350\u2013360. doi: 10.1016/j.ejmech.2016.08.065.", "ArticleIdList": ["10.1016/j.ejmech.2016.08.065", "27597411"]}, {"Citation": "Ammar Y.A., Fayed E.A., Bayoumi A.H., Ezz R.R., Alsaid M.S., Soliman A.M., Ghorab M.M. New chalcones bearing isatin scaffold: Synthesis, molecular modeling and biological evaluation as anticancer agents. Res. Chem. Intermed. 2017;43:6765\u20136786. doi: 10.1007/s11164-017-3019-z.", "ArticleIdList": ["10.1007/s11164-017-3019-z"]}, {"Citation": "Abdel-Aziz H.A., Eldehna W.M., Keeton A.B., Piazza G.A., Kadi A.A., Attwa M.W., Abdelhameed A.S., Attia M.I. Isatin-benzoazine molecular hybrids as potential antiproliferative agents: Synthesis and in vitro pharmacological profiling. Drug Des. Devel. Ther. 2017;11:2333\u20132346. doi: 10.2147/DDDT.S140164.", "ArticleIdList": ["10.2147/DDDT.S140164", "PMC5557401", "28848327"]}, {"Citation": "Eldehna W.M., Abo-Ashour M.F., Nocentini A., Gratteri P., Eissa I.H., Fares M., Ismael O.E., Ghabbour H.A., Elaasser M.M., Abdel-Aziz H.A., et al. Novel 4/3-((4-oxo-5-(2-oxoindolin-3-ylidene)thiazolidin-2-ylidene)amino) benzenesulfonamides: Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies. Eur. J. Med. Chem. 2017;139:250\u2013262. doi: 10.1016/j.ejmech.2017.07.073.", "ArticleIdList": ["10.1016/j.ejmech.2017.07.073", "28802125"]}, {"Citation": "Gabr M.T., El-Gohary N.S., El-Bendary E.R., El-Kerdawy M.M., Ni N. Isatin-\u03b2-thiocarbohydrazones: Microwave-assisted synthesis, antitumor activity and structure-activity relationship. Eur. J. Med. Chem. 2017;128:36\u201344. doi: 10.1016/j.ejmech.2017.01.030.", "ArticleIdList": ["10.1016/j.ejmech.2017.01.030", "28147307"]}, {"Citation": "Gangarapu K., Thumma G., Manda S., Jallapally A., Jarapula R., Rekulapally S. Design, synthesis and molecular docking of novel structural hybrids of substituted isatin based pyrazoline and thiadiazoline as antitumor agents. Med. Chem. Res. 2017;26:819\u2013829. doi: 10.1007/s00044-017-1781-5.", "ArticleIdList": ["10.1007/s00044-017-1781-5"]}, {"Citation": "Li W., Zhao S.-J., Gao F., Lv Z.-S., Tu J.-Y., Xu Z. Synthesis and in Vitro Anti-Tumor, Anti-Mycobacterial and Anti-HIV Activities of Diethylene-Glycol-Tethered Bis-Isatin Derivatives. ChemistrySelect. 2018;3:10250\u201310254. doi: 10.1002/slct.201802185.", "ArticleIdList": ["10.1002/slct.201802185"]}, {"Citation": "Ammar Y.A., El-Sharief A.M.S., Belal A., Abbas S.Y., Mohamed Y.A., Mehany A.B.M., Ragab A. Design, synthesis, antiproliferative activity, molecular docking and cell cycle analysis of some novel (morpholinosulfonyl) isatins with potential EGFR inhibitory activity. Eur. J. Med. Chem. 2018;156:918\u2013932. doi: 10.1016/j.ejmech.2018.06.061.", "ArticleIdList": ["10.1016/j.ejmech.2018.06.061", "30096580"]}, {"Citation": "Zou Y. Benzofuran-isatin conjugates as potent VEGFR-2 and cancer cell growth inhibitors. J. Heterocycl. Chem. 2020;57:510\u2013516. doi: 10.1002/jhet.3795.", "ArticleIdList": ["10.1002/jhet.3795"]}, {"Citation": "Alkahtani H.M., Alanazi M.M., Aleanizy F.S., Alqahtani F.Y., Alhoshani A., Alanazi F.E., Almehizia A.A., Abdalla A.N., Alanazi M.G., El-Azab A.S., et al. Synthesis, anticancer, apoptosis-inducing activities and EGFR and VEGFR2 assay mechanistic studies of 5,5-diphenylimidazolidine-2,4-dione derivatives: Molecular docking studies. Saudi Pharm. J. 2019;27:682\u2013693. doi: 10.1016/j.jsps.2019.04.003.", "ArticleIdList": ["10.1016/j.jsps.2019.04.003", "PMC6598223", "31297023"]}, {"Citation": "Xu K., Liu Y., Wang R., Cai P., Fang Y. Design, Synthesis, and Anticancer Activities of Benzofuran\u2013Isatin Hybrids Tethered by Pentylene and Hexylene. J. Heterocycl. Chem. 2019;56:2052\u20132055. doi: 10.1002/jhet.3586.", "ArticleIdList": ["10.1002/jhet.3586"]}, {"Citation": "Jiang D., Zhang G. Ciprofloxacin/Gatifloxacin-1,2,3-triazole-isatin Hybrids and Their in Vitro Anticancer Activity. J. Heterocycl. Chem. 2019;56:2966\u20132969. doi: 10.1002/jhet.3684.", "ArticleIdList": ["10.1002/jhet.3684"]}, {"Citation": "Al-Wabli R.I., Almomen A.A., Almutairi M.S., Keeton A.B., Piazza G.A., Attia M.I. New Isatin-Indole Conjugates: Synthesis, Characterization, and a Plausible Mechanism of Their in vitro Antiproliferative Activity. Drug Des. Devel. Ther. 2020;14:483\u2013495. doi: 10.2147/DDDT.S227862.", "ArticleIdList": ["10.2147/DDDT.S227862", "PMC7006853", "32099332"]}, {"Citation": "Rajesh Kumar M., Violet Dhayabaran V., Sudhapriya N., Manikandan A., Gideon D.A., Annapoorani S. p-TSA.H2O mediated one-pot, multi-component synthesis of isatin derived imidazoles as dual-purpose drugs against inflammation and cancer. Bioorg. Chem. 2020;102:104046. doi: 10.1016/j.bioorg.2020.104046.", "ArticleIdList": ["10.1016/j.bioorg.2020.104046", "32688115"]}, {"Citation": "Nazari S., Safari F., Mamaghani M.B., Bazgir A. Synthesis and evaluation of in vitro cytotoxic effects of triazol/spiroindolinequinazolinedione, triazol/indolin-3-thiosemicarbazone and triazol/thiazol-indolin-2-one conjugates. DARU J. Pharm. Sci. 2020;28:591\u2013601. doi: 10.1007/s40199-020-00364-7.", "ArticleIdList": ["10.1007/s40199-020-00364-7", "PMC7704989", "32803690"]}, {"Citation": "Shaikh M.H., Subhedar D.D., Khan F.A.K., Sangshetti J.N., Nawale L., Arkile M., Sarkar D., Shingate B.B. Synthesis of Novel Triazole-incorporated Isatin Derivatives as Antifungal, Antitubercular, and Antioxidant Agents and Molecular Docking Study. J. Heterocycl. Chem. 2017;54:413\u2013421. doi: 10.1002/jhet.2598.", "ArticleIdList": ["10.1002/jhet.2598"]}, {"Citation": "Borad M.A., Bhoi M.N., Rathwa S.K., Vasava M.S., Patel H.D., Patel C.N., Pandya H.A., Pithawala E.A., Georrge J.J. Microwave-Assisted ZrSiO2 Catalysed Synthesis, Characterization and Computational Study of Novel Spiro[Indole-Thiazolidines] Derivatives as Anti-tubercular Agents. Interdiscip. Sci. Comput. Life Sci. 2018;10:411\u2013418. doi: 10.1007/s12539-016-0195-2.", "ArticleIdList": ["10.1007/s12539-016-0195-2", "27837427"]}, {"Citation": "Xu Z., Zhang S., Song X., Qiang M., Lv Z. Design, synthesis and in vitro anti-mycobacterial evaluation of gatifloxacin-1H-1,2,3-triazole-isatin hybrids. Bioorg. Med. Chem. Lett. 2017;27:3643\u20133646. doi: 10.1016/j.bmcl.2017.07.023.", "ArticleIdList": ["10.1016/j.bmcl.2017.07.023", "28720502"]}, {"Citation": "Hu Y.-Q., Meng L.-D., Qiang M., Song X.-F. Design, Synthesis, and in Vitro Anti-mycobacterial Evaluation 1H-1,2,3-triazole-tethered Ciprofloxacin and Isatin Conjugates. J. Heterocycl. Chem. 2017;54:3725\u20133729. doi: 10.1002/jhet.2933.", "ArticleIdList": ["10.1002/jhet.2933"]}, {"Citation": "Yan X., Lv Z., Wen J., Zhao S., Xu Z. Synthesis and in vitro evaluation of novel substituted isatin-propylene-1H-1,2,3-triazole-4-methylene-moxifloxacin hybrids for their anti-mycobacterial activities. Eur. J. Med. Chem. 2018;143:899\u2013904. doi: 10.1016/j.ejmech.2017.11.090.", "ArticleIdList": ["10.1016/j.ejmech.2017.11.090", "29227930"]}, {"Citation": "Xu Z., Song X.-F., Qiang M., Lv Z.-S. 1H-1,2,3-triazole-tethered 8-OMe Ciprofloxacin and Isatin Hybrids: Design, Synthesis and in vitro Anti-mycobacterial Activities. J. Heterocycl. Chem. 2017;54:3735\u20133741. doi: 10.1002/jhet.2980.", "ArticleIdList": ["10.1002/jhet.2980"]}, {"Citation": "Xu Z., Lv Z.-S., Song X.-F., Qiang M. Ciprofloxacin-isatin-1H-1,2,3-triazole Hybrids: Design, Synthesis, and in vitro Anti-tubercular Activity against M. tuberculosis. J. Heterocycl. Chem. 2018;55:97\u2013102. doi: 10.1002/jhet.3010.", "ArticleIdList": ["10.1002/jhet.3010"]}, {"Citation": "Xu Y., Guan J., Xu Z., Zhao S. Design, synthesis and in vitro anti-mycobacterial activities of homonuclear and heteronuclear bis-isatin derivatives. Fitoterapia. 2018;127:383\u2013386. doi: 10.1016/j.fitote.2018.03.018.", "ArticleIdList": ["10.1016/j.fitote.2018.03.018", "29631015"]}, {"Citation": "Zhao S.-Q., Xu Y., Guan J., Zhao S., Zhang G.-D., Xu Z. Tetraethylene Glycol Tethered Heteronuclear Bis-isatin Derivatives: Design, Synthesis, and in Vitro Anti-mycobacterial Activities. J. Heterocycl. Chem. 2018;55:2172\u20132177. doi: 10.1002/jhet.3255.", "ArticleIdList": ["10.1002/jhet.3255"]}, {"Citation": "Gao F., Yang H., Lu T., Chen Z., Ma L., Xu Z., Schaffer P., Lu G. Design, synthesis and anti-mycobacterial activity evaluation of benzofuran-isatin hybrids. Eur. J. Med. Chem. 2018;159:277\u2013281. doi: 10.1016/j.ejmech.2018.09.049.", "ArticleIdList": ["10.1016/j.ejmech.2018.09.049", "30296686"]}, {"Citation": "Hua X., Zhang G., Zhang D., Wu Y. Design, Synthesis, and in vitro Anti-mycobacterial Activities of Propylene-tethered Heteronuclear Bis-isatin Derivatives. J. Heterocycl. Chem. 2018;55:1504\u20131508. doi: 10.1002/jhet.3185.", "ArticleIdList": ["10.1002/jhet.3185"]}, {"Citation": "Gao T., Zeng Z., Wang G., Sun S., Liu Y. Synthesis of Ethylene Tethered Isatin-Coumarin Hybrids and Evaluation of Their in vitro Antimycobacterial Activities. J. Heterocycl. Chem. 2018;55:1484\u20131488. doi: 10.1002/jhet.3161.", "ArticleIdList": ["10.1002/jhet.3161"]}, {"Citation": "Wang H.-D., Fan Y.-L., Zhou J., Xu Y., Guan J. Design, Synthesis, and in Vitro Anti-mycobacterial Activities of Propylene-Tethered Gatifloxacin-Isatin Hybrids. J. Heterocycl. Chem. 2018;55:1991\u20131996. doi: 10.1002/jhet.3227.", "ArticleIdList": ["10.1002/jhet.3227"]}, {"Citation": "Xu Y., Dang R., Guan J., Xu Z., Zhao S., Hu Y. Isatin-(thio)semicarbazide/oxime-1H-1,2,3-triazole-coumarin Hybrids: Design, Synthesis, and in vitro Anti-mycobacterial Evaluation. J. Heterocycl. Chem. 2018;55:1069\u20131073. doi: 10.1002/jhet.3104.", "ArticleIdList": ["10.1002/jhet.3104"]}, {"Citation": "Jialun D., Liu X.-C., Guangwei C., Gang Z., Li H., Li Q., Ziyong L., Xu Z. Heteronuclear 5-Fluoroisatin Dimers: Design, Synthesis, and Evaluation of Their in Vitro Anti-mycobacterial Activities: Heteronuclear 5-Fluoroisatin Dimers. J. Heterocycl. Chem. 2018;55:1509\u20131513."}, {"Citation": "Wang R., Yin X., Zhang Y., Yan W. Design, synthesis and antimicrobial evaluation of propylene-tethered ciprofloxacin-isatin hybrids. Eur. J. Med. Chem. 2018;156:580\u2013586. doi: 10.1016/j.ejmech.2018.07.025.", "ArticleIdList": ["10.1016/j.ejmech.2018.07.025", "30025351"]}, {"Citation": "Gao F., Wang T., Gao M., Zhang X., Liu Z., Zhao S., Lv Z., Xiao J. Benzofuran-isatin-imine hybrids tethered via different length alkyl linkers: Design, synthesis and in vitro evaluation of anti-tubercular and anti-bacterial activities as well as cytotoxicity. Eur. J. Med. Chem. 2019;165:323\u2013331. doi: 10.1016/j.ejmech.2019.01.042.", "ArticleIdList": ["10.1016/j.ejmech.2019.01.042", "30690301"]}, {"Citation": "Gao F., Ye L., Wang Y., Kong F., Zhao S., Xiao J., Huang G. Benzofuran-isatin hybrids and their in vitro anti-mycobacterial activities against multi-drug resistant Mycobacterium tuberculosis. Eur. J. Med. Chem. 2019;183:111678. doi: 10.1016/j.ejmech.2019.111678.", "ArticleIdList": ["10.1016/j.ejmech.2019.111678", "31525660"]}, {"Citation": "Gao F., Chen Z., Ma L., Fan Y., Chen L., Lu G. Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains. Eur. J. Med. Chem. 2019;180:648\u2013655. doi: 10.1016/j.ejmech.2019.07.057.", "ArticleIdList": ["10.1016/j.ejmech.2019.07.057", "31352245"]}, {"Citation": "Chen R., Zhang H., Ma T., Xue H., Miao Z., Chen L., Shi X. Ciprofloxacin-1,2,3-triazole-isatin hybrids tethered via amide: Design, synthesis, and in vitro anti-mycobacterial activity evaluation. Bioorg. Med. Chem. Lett. 2019;29:2635\u20132637. doi: 10.1016/j.bmcl.2019.07.041.", "ArticleIdList": ["10.1016/j.bmcl.2019.07.041", "31358466"]}, {"Citation": "Liu B., Wang G.-Q., Peng Y.-H., Tang X.-Q., Hu G.-W. Design, synthesis, and in vitro antimycobacterial activities of butylene tethered 7-fluoroisatin-isatin scaffolds. J. Heterocycl. Chem. 2019;56:3423\u20133428. doi: 10.1002/jhet.3696.", "ArticleIdList": ["10.1002/jhet.3696"]}, {"Citation": "Ding Z., Hou P., Liu B. Gatifloxacin-1,2,3-triazole-isatin hybrids and their antimycobacterial activities. Arch. Pharm. 2019;352:e1900135. doi: 10.1002/ardp.201900135.", "ArticleIdList": ["10.1002/ardp.201900135", "31441087"]}, {"Citation": "Elsayed Z.M., Eldehna W.M., Abdel-Aziz M.M., El Hassab M.A., Elkaeed E.B., Al-Warhi T., Abdel-Aziz H.A., Abou-Seri S.M., Mohammed E.R. Development of novel isatin-nicotinohydrazide hybrids with potent activity against susceptible/resistant Mycobacterium tuberculosis and bronchitis causing-bacteria. J. Enzym. Inhib. Med. Chem. 2021;36:384\u2013393. doi: 10.1080/14756366.2020.1868450.", "ArticleIdList": ["10.1080/14756366.2020.1868450", "PMC7801109", "33406941"]}, {"Citation": "Lian Z.-M., Sun J., Zhu H.-L. Design, synthesis and antibacterial activity of isatin derivatives as FtsZ inhibitors. J. Mol. Struct. 2016;1117:8\u201316. doi: 10.1016/j.molstruc.2016.03.036.", "ArticleIdList": ["10.1016/j.molstruc.2016.03.036"]}, {"Citation": "Al-Wabli R.I., Zakaria A.S., Attia M.I. Synthesis, Spectroscopic Characterization and Antimicrobial Potential of Certain New Isatin-Indole Molecular Hybrids. Molecules. 2017;22:1958. doi: 10.3390/molecules22111958.", "ArticleIdList": ["10.3390/molecules22111958", "PMC6150181", "29140257"]}, {"Citation": "Kenchappa R., Bodke Y.D., Telkar S., Nagaraja O. Synthesis and antimicrobial activity of fused isatin and diazepine derivatives derived from 2-acetyl benzofuran. Russ. J. Gen. Chem. 2017;87:2027\u20132038. doi: 10.1134/S1070363217090195.", "ArticleIdList": ["10.1134/S1070363217090195"]}, {"Citation": "Almutairi M., Zakaria A., Primsa I.P., Al-wabli R., Joe I.H., Attia M. Synthesis, spectroscopic investigations, DFT studies, molecular docking and antimicrobial potential of certain new indole-isatin molecular hybrids: Experimental and theoretical approaches. J. Mol. Struct. 2017;1153:335\u2013345. doi: 10.1016/j.molstruc.2017.10.025.", "ArticleIdList": ["10.1016/j.molstruc.2017.10.025"]}, {"Citation": "Bogdanov A.V., Zaripova I.F., Voloshina A.D., Strobykina A.S., Kulik N.V., Bukharov S.V., Voronina J.K., Khamatgalimov A.R., Mironov V.F. Synthesis and antimicrobial activity evaluation of some novel water-soluble isatin-3-acylhydrazones. Mon. F\u00fcr Chem.-Chem. Mon. 2018;149:111\u2013117. doi: 10.1007/s00706-017-2049-y.", "ArticleIdList": ["10.1007/s00706-017-2049-y"]}, {"Citation": "Singh G., Arora A., Singh A., Kalra P., Rani S., Singh K., Maurya I.K., Mandal R.S. Molecular Design, Synthesis, Computational Screening, Antimicrobial Evaluation and Molecular Docking Study of Acetylinic Isatin Hybrids. ChemistrySelect. 2018;3:1942\u20131952. doi: 10.1002/slct.201703051.", "ArticleIdList": ["10.1002/slct.201703051"]}, {"Citation": "Gomaa M.A.-M., Hassan D.K. Synthesis, characterization, and antimicrobial activity of some new N-aryl-N\u2032-(2-oxoindolin-3-ylidene)-benzohydrazonamides. Arch. Pharm. 2019;352:e1900209. doi: 10.1002/ardp.201900209.", "ArticleIdList": ["10.1002/ardp.201900209", "31621127"]}, {"Citation": "Gao F., Ye L., Kong F., Huang G., Xiao J. Design, synthesis and antibacterial activity evaluation of moxifloxacin-amide-1,2,3-triazole-isatin hybrids. Bioorg. Chem. 2019;91:103162. doi: 10.1016/j.bioorg.2019.103162.", "ArticleIdList": ["10.1016/j.bioorg.2019.103162", "31382058"]}, {"Citation": "Bhagat K., Bhagat J., Gupta M.K., Singh J.V., Gulati H.K., Singh A., Kaur K., Kaur G., Sharma S., Rana A., et al. Design, Synthesis, Antimicrobial Evaluation, and Molecular Modeling Studies of Novel Indolinedione\u2013Coumarin Molecular Hybrids. ACS Omega. 2019;4:8720\u20138730. doi: 10.1021/acsomega.8b02481.", "ArticleIdList": ["10.1021/acsomega.8b02481", "PMC6648594", "31459961"]}, {"Citation": "Lahari K., Sundararajan R. Design and synthesis of novel isatin derivatives as potent analgesic, anti-inflammatory and antimicrobial agents. J. Chem. Sci. 2020;132:94. doi: 10.1007/s12039-020-01795-0.", "ArticleIdList": ["10.1007/s12039-020-01795-0"]}, {"Citation": "Mangasuli S. Synthesis of novel Isatin-Dithiocarbamate hybrids: An approach to Microwave and potent antimicrobial agents. Chem. Data Collect. 2020;29:100515. doi: 10.1016/j.cdc.2020.100515.", "ArticleIdList": ["10.1016/j.cdc.2020.100515"]}, {"Citation": "Rawat P., Verma S.M. Design and synthesis of chroman derivatives with dual anti-breast cancer and antiepileptic activities. Drug Des. Devel. Ther. 2016;10:2779\u20132788. doi: 10.2147/DDDT.S111266.", "ArticleIdList": ["10.2147/DDDT.S111266", "PMC5015874", "27621598"]}, {"Citation": "Rahmani-Khajouei M., Mohammadi-Farani A., Mirzaei D., Aliabadi A. Isatin-based anticonvulsant agents: Synthesis and antiseizure evaluation in mice. J. Rep. Pharm. Sci. 2017;6:13\u201322. doi: 10.22110/JRPS.2017.10221.", "ArticleIdList": ["10.22110/JRPS.2017.10221"]}, {"Citation": "Divar M., Yeganeh Y., Jamshidzadeh A., Reza Heidari S.K. Anticonvulsant activity of some semicarbazone and thiosemicarbazone derivatives of isatin on PTZ induced seizure. J. Innov. Appl. Pharm. Sci. 2017;2:4\u201314."}, {"Citation": "Kiranmai M. Synthesis and Evaluation of Some Novel N, N-Dialkylaminoalkoxy-2-Oxo-Indole-3-Ylidene Benzohydrazides as Anticonvulsant Agents. IOSR J. Pharm. Biol. Sci. 2017;12:84\u201393. doi: 10.9790/3008-1202028493.", "ArticleIdList": ["10.9790/3008-1202028493"]}, {"Citation": "Khajouei M.R., Mohammadi-Farani A., Moradi A., Aliabadi A. Synthesis and evaluation of anticonvulsant activity of (Z)-4-(2-oxoindolin-3-ylideneamino)-N-phenylbenzamide derivatives in mice. Res. Pharm. Sci. 2018;13:262\u2013272. doi: 10.4103/1735-5362.228956.", "ArticleIdList": ["10.4103/1735-5362.228956", "PMC5921406", "29853935"]}, {"Citation": "Nath R., Shahar Yar M., Pathania S., Grover G., Debnath B., Akhtar M.J. Synthesis and anticonvulsant evaluation of indoline derivatives of functionalized aryloxadiazole amine and benzothiazole acetamide. J. Mol. Struct. 2021;1228:129742. doi: 10.1016/j.molstruc.2020.129742.", "ArticleIdList": ["10.1016/j.molstruc.2020.129742"]}, {"Citation": "Thanh N.D., Giang N.T.K., Quyen T.H., Huong D.T., Toan V.N. Synthesis and evaluation of in vivo antioxidant, in vitro antibacterial, MRSA and antifungal activity of novel substituted isatin N-(2,3,4,6-tetra-O-acetyl-\u03b2-d-glucopyranosyl)thiosemicarbazones. Eur. J. Med. Chem. 2016;123:532\u2013543. doi: 10.1016/j.ejmech.2016.07.074.", "ArticleIdList": ["10.1016/j.ejmech.2016.07.074", "27517802"]}, {"Citation": "Haribabu J., Subhashree G.R., Saranya S., Gomathi K., Karvembu R., Gayathri D. Isatin based thiosemicarbazone derivatives as potential bioactive agents: Anti-oxidant and molecular docking studies. J. Mol. Struct. 2016;1110:185\u2013195. doi: 10.1016/j.molstruc.2016.01.044.", "ArticleIdList": ["10.1016/j.molstruc.2016.01.044"]}, {"Citation": "El-Serwy W., Mohamed N., El-Serwy W., Kassem E., Shalaby A. Synthesis, antioxidant, anticoagulant, and fibrinolytic activities of new isatin derivative. Egypt. Pharm. J. 2020;19:113. doi: 10.4103/epj.epj_52_19.", "ArticleIdList": ["10.4103/epj.epj_52_19"]}, {"Citation": "Jarapula R., Gangarapu K., Manda S., Rekulapally S. Synthesis, in Vivo Anti-Inflammatory Activity, and Molecular Docking Studies of New Isatin Derivatives. Int. J. Med. Chem. 2016;2016:2181027. doi: 10.1155/2016/2181027.", "ArticleIdList": ["10.1155/2016/2181027", "PMC4769772", "27022484"]}, {"Citation": "Sharma P.K., Balwani S., Mathur D., Malhotra S., Singh B.K., Prasad A.K., Len C., Van der Eycken E.V., Ghosh B., Richards N.G.J., et al. Synthesis and anti-inflammatory activity evaluation of novel triazolyl-isatin hybrids. J. Enzym. Inhib. Med. Chem. 2016;31:1520\u20131526. doi: 10.3109/14756366.2016.1151015.", "ArticleIdList": ["10.3109/14756366.2016.1151015", "27146339"]}, {"Citation": "Ibrahim M.M., Elsaman T., Al-Nour M.Y. Synthesis, Anti-Inflammatory Activity, and in Silico Study of Novel Diclofenac and Isatin Conjugates. Int. J. Med. Chem. 2018;2018:9139786. doi: 10.1155/2018/9139786.", "ArticleIdList": ["10.1155/2018/9139786", "PMC6020500", "30009055"]}, {"Citation": "Wang G., Wang J., He D., Li X., Li J., Peng Z. Synthesis, in vitro evaluation and molecular docking studies of novel coumarin-isatin derivatives as \u03b1-glucosidase inhibitors. Chem. Biol. Drug Des. 2017;89:456\u2013463. doi: 10.1111/cbdd.12867.", "ArticleIdList": ["10.1111/cbdd.12867", "27616456"]}, {"Citation": "Xie Z., Wang G., Wang J., Chen M., Peng Y., Li L., Deng B., Chen S., Li W. Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel Isatin-Thiazole Derivatives as \u03b1-Glucosidase Inhibitors. Molecules. 2017;22:659. doi: 10.3390/molecules22040659.", "ArticleIdList": ["10.3390/molecules22040659", "PMC6154535", "28425975"]}, {"Citation": "Wang G., Chen M., Qiu J., Xie Z., Cao A. Synthesis, in vitro \u03b1-glucosidase inhibitory activity and docking studies of novel chromone-isatin derivatives. Bioorg. Med. Chem. Lett. 2018;28:113\u2013116. doi: 10.1016/j.bmcl.2017.11.047.", "ArticleIdList": ["10.1016/j.bmcl.2017.11.047", "29208524"]}, {"Citation": "Altowyan M.S., Barakat A., Al-Majid A.M., Al-Ghulikah H.A. Spiroindolone Analogues as Potential Hypoglycemic with Dual Inhibitory Activity on \u03b1-Amylase and \u03b1-Glucosidase. Molecules. 2019;24:2342. doi: 10.3390/molecules24122342.", "ArticleIdList": ["10.3390/molecules24122342", "PMC6630796", "31242688"]}, {"Citation": "Devale T.L., Parikh J., Miniyar P., Sharma P., Shrivastava B., Murumkar P. Dihydropyrimidinone-isatin hybrids as novel non-nucleoside HIV-1 reverse transcriptase inhibitors. Bioorg. Chem. 2017;70:256\u2013266. doi: 10.1016/j.bioorg.2017.01.006.", "ArticleIdList": ["10.1016/j.bioorg.2017.01.006", "28160944"]}, {"Citation": "Zhang L., Zhao S., Xu Z., Liu Y. Investigation of the Anti-human Immunodeficiency Virus Activity of Heteronuclear Bis-isatin Scaffolds Tethered through Propyl and Butyl. J. Heterocycl. Chem. 2019;56:2975\u20132979. doi: 10.1002/jhet.3691.", "ArticleIdList": ["10.1002/jhet.3691"]}, {"Citation": "ClinicalTrials.gov.  [(accessed on 15 December 2021)]; Available online:  https://clinicaltrials.gov."}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "12", "Day": "20"}, {"Year": "2022", "Month": "1", "Day": "29"}, {"Year": "2022", "Month": "1", "Day": "30"}, {"Year": "2022", "Month": "3", "Day": "26", "Hour": "1", "Minute": "8"}, {"Year": "2022", "Month": "3", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "27", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "2", "Day": "22"}], "PublicationStatus": "epublish", "ArticleIdList": ["35337070", "PMC8950263", "10.3390/ph15030272", "ph15030272"]}}], "PubmedBookArticle": []}